Matches in Nanopublications for { ?s ?p "[Strong clinical and experimental evidence shows that elevated levels of urokinase plasminogen activators (u-PA) and matrix metalloproteinases (MMPs) are associated with prostate cancer progression, metastasis and shortened survival in patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 3 of
3
with 100 items per page.
- NP336646.RABIGA7-XYWFXjRury7_Wo6vJaoKjj2hF-phW-oqYvOjA130_assertion description "[Strong clinical and experimental evidence shows that elevated levels of urokinase plasminogen activators (u-PA) and matrix metalloproteinases (MMPs) are associated with prostate cancer progression, metastasis and shortened survival in patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP336646.RABIGA7-XYWFXjRury7_Wo6vJaoKjj2hF-phW-oqYvOjA130_provenance.
- NP391453.RAnRSxA3jQ67vUD4Hhj_vjkyiOCcApSWzpDp7nMwiXDXc130_assertion description "[Strong clinical and experimental evidence shows that elevated levels of urokinase plasminogen activators (u-PA) and matrix metalloproteinases (MMPs) are associated with prostate cancer progression, metastasis and shortened survival in patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP391453.RAnRSxA3jQ67vUD4Hhj_vjkyiOCcApSWzpDp7nMwiXDXc130_provenance.
- NP264507.RAuswyi5fuE3HDKElJJpcJEoLSJ2cvbXcTI1QBhPXiZyo130_assertion description "[Strong clinical and experimental evidence shows that elevated levels of urokinase plasminogen activators (u-PA) and matrix metalloproteinases (MMPs) are associated with prostate cancer progression, metastasis and shortened survival in patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP264507.RAuswyi5fuE3HDKElJJpcJEoLSJ2cvbXcTI1QBhPXiZyo130_provenance.